Vinorelbine
Showing 576 - 598 of 598
Advanced NSCLC Trial in Italy (Pemetrexed, Pemetrexed plus carboplatin)
Unknown status
- Advanced Non-Small Cell Lung Cancer
- Pemetrexed
- Pemetrexed plus carboplatin
-
Ancona, Italy
- +20 more
Jul 31, 2009
Locally Advanced Non Small-Cell Lung Canger Trial in Mexico city (Transdermal nitroglycerin)
Unknown status
- Locally Advanced Non Small-Cell Lung Canger
- Transdermal nitroglycerin
-
Mexico city, Distrito federal, MexicoNational Institute of Cancerología
Apr 21, 2009
Non Small Cell Lung Cancer Trial in Guangzhou (Pemetrexed/Oxaliplatin)
Unknown status
- Non Small Cell Lung Cancer
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Guangzhou Medical College
Jun 17, 2009
Metastatic Breast Cancer Trial in Columbus, Newark (Doxil and Vinorelbine)
Unknown status
- Metastatic Breast Cancer
- Doxil and Vinorelbine
-
Columbus, Ohio
- +1 more
May 30, 2008
NSCLC Trial in Taipei (Taxotere, Cisplatin, Gemcitabine)
Unknown status
- Carcinoma, Non-Small-Cell Lung
- Taxotere, Cisplatin, Gemcitabine
-
Taipei, Ban-Ciao, TaiwanChi-Huang Hsiao
Feb 6, 2009
Breast Cancer Trial in Copenhagen (docetaxel, vinorelbine, trastuzumab)
Unknown status
- Breast Cancer
- docetaxel
- +2 more
-
Copenhagen, DenmarkDepartment of Oncology, Rigshospitalet
May 6, 2008
NSCLC, Measles Trial in Beer Sheva (attenuated measles vaccine)
Unknown status
- Non-Small Cell Lung Cancer
- Measles
- attenuated measles vaccine
-
Beer Sheva, IsraelDepartment of Oncology, Soroka Medical Center
Jan 22, 2009
NSCLC Trial in Germany (Erlotinib, Vinorelbine and Carboplatin)
Unknown status
- Non-Small Cell Lung Cancer
- Erlotinib
- Vinorelbine and Carboplatin
-
Augsburg, Germany
- +39 more
May 15, 2008
Breast Cancer, Cancer, Lung Cancer Trial run by the NCI (Vinorelbine, XR9576)
Completed
- Breast Cancer
- +3 more
- Vinorelbine
- XR9576
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Breast Cancer, Non Small Cell Lung Cancer, Prostate Cancer Trial in Greece (vinorelbine oral formulation)
Completed
- Breast Cancer
- +2 more
- vinorelbine oral formulation
-
Athens, Greece
- +10 more
Feb 27, 2008
NSCLC Trial in France (Gefitinib, Radiation therapy, Cisplatin)
Completed
- Non-Small Cell Lung Cancer
- Gefitinib
- +3 more
-
Clermont Ferrand, France
- +3 more
Dec 16, 2007
Breast Tumor Trial in Seattle (Docetaxel, Vinorelbine, Filgrastim)
Completed
- Breast Neoplasm
- Docetaxel
- +2 more
-
Seattle, WashingtonUniversity of Washington/Seattle Cancer Care Alliance
Dec 3, 2007
Non-Small-Cell Lung Carcinoma Trial in Kassel (Gemcitabine, Navelbine, Carboplatin)
Completed
- Non-Small-Cell Lung Carcinoma
- Gemcitabine
- +5 more
-
Kassel, GermanyKlinikum Kassel GmbH
Apr 21, 2008
NSCLC Trial in cOIMBRA (CETUXIMAB)
Unknown status
- Carcinoma, Non-Small-Cell Lung
-
cOIMBRA, PortugalfERNANDO bARATA
Nov 19, 2007
NSCLC Trial in Berlin (Carboplatin, Paclitaxel, Vinorelbine)
Unknown status
- Carcinoma, Non-Small-Cell Lung
- Carboplatin
- +2 more
-
Berlin, GermanyHematology & Oncology Charité CBF Berlin
Oct 31, 2006
Rhabdomyosarcomas, Tumors, Connective and Soft Tissue, Ewing Tumor Trial in Villejuif (Vinorelbine, cyclofosfamide)
Unknown status
- Rhabdomyosarcomas
- +5 more
- Vinorelbine, cyclofosfamide
-
Villejuif, FranceInstitut Gustave-Roussy
Sep 7, 2006
NSCLC Trial in United States (calcitriol + docetaxel)
Completed
- Carcinoma, Non-Small-Cell Lung
- calcitriol + docetaxel
-
Berkeley, California
- +10 more
May 3, 2007
Lung Cancer Trial (Patients were randomized to receive either docetaxel 60 mg/m2 on day 1 or vinorelbine 25 mg/m2 on days 1and
Completed
- Lung Cancer
- Patients were randomized to receive either docetaxel 60 mg/m2 on day 1 or vinorelbine 25 mg/m2 on days 1and 8, repeated every 21 days over four cycles.
- (no location specified)
Jan 5, 2006
NSCLC Trial in Seoul (vinorelbine, gemcitabine and carboplatin)
Unknown status
- Non-Small Cell Lung Cancer
- vinorelbine, gemcitabine and carboplatin
-
Seoul, Korea, Republic ofInje University Sanggyepaik Hospital
Dec 14, 2005